India's Bioeconomy & BioE3 Policy
India's bioeconomy — the share of the economy built on biological inputs and biotechnology, from vaccines and biosimilars to industrial enzymes, biofuels and bio-based chemicals — crossed $195.3 billion in 2025, about 4.8% of GDP and nearly twenty times its 2014 size. The India BioEconomy Report 2026, released by BIRAC on its 14th Foundation Day, clocks 18% growth for the year and fixes a $300 billion goal for 2030. Underpinning that ambition is the 2024 BioE3 policy, which pivots public support toward high-performance biomanufacturing, alongside a ₹1 lakh crore innovation fund and the ₹10,000-crore Biopharma SHAKTI scheme for biologics.
Read the full living note — free
The complete note in both exam lenses (UPSC analytical / fact capsule), its full version history, and “what changed since you last read” — plus tonight's quiz.
Open in CA·WikiAI-assisted, human-reviewed · sourced from PIB, RBI & ministries · editorial policy